Cover Image

Effectiveness of anti-mullerian hormone-tailored protocol compared to conventional protocol in women undergoing in vitro fertilization: A randomized controlled trial

Background: Assessment of ovarian reserve before an in vitro fertilization cycle (IVF) is one among the many factors that predicts a successful cycle. Individualized protocol based on ovarian reserve is designed to optimize the pregnancy outcome without compromising the patient safety. Although auth...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sumi Thomas (Author), Mousumi Acharya (Author), K Muthukumar (Author), Achamma Chandy (Author), Mohan S Kamath (Author), T K Aleyamma (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2018-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age
by: Chi-Chun Liao, et al.
Published: (2016)

Obstetric outcomes of monochorionic pregnancies conceived following assisted reproductive technology: A retrospective study
by: Mariano Mascarenhas, et al.
Published: (2014)

Comparison of clinical outcomes following vitrified warmed day 5/6 blastocyst transfers using solid surface methodology with fresh blastocyst transfers
by: K Muthukumar, et al.
Published: (2013)

Comparison of perinatal outcomes of singletons following vanishing twin phenomenon and singletons with initial single gestational sac conceived following assisted reproductive technology: A retrospective analysis
by: Treasa Joseph, et al.
Published: (2019)

Discordance between antral follicle counts and anti-Müllerian hormone levels in women undergoing in vitro fertilization
by: Yangyang Zhang, et al.
Published: (2019)

Anti-Müllerian Hormone in Fertility Preservation: Clinical and Therapeutic Applications
by: Charlotte Sonigo, et al.
Published: (2019)

Patient experience with conscious sedation as a method of pain relief for transvaginal oocyte retrieval: A cross sectional study
by: Himanshu Singhal, et al.
Published: (2017)

Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India
by: Kavita Mandrelle, et al.
Published: (2012)

Effects of anti-Müllerian hormone and follicle stimulating hormone levels on in vitro fertilization pregnancy rate
by: Yi-Pin Chen, et al.
Published: (2014)

The relationship between anti-mullerian hormone and ovarian response and fertility outcome in infertile women undergoing assisted reproductive techniques (ART) and IUI
by: Fariba Seyedoshohadaei, et al.
Published: (2023)

Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?
by: Shunping Wang, et al.
Published: (2018)

Follicular-fluid anti-Mullerian hormone (FF AMH) is a plausible biochemical indicator of functional viability of oocyte in conventional in vitro fertilization (IVF) cycles
by: Bindu N Mehta, et al.
Published: (2013)

The Relationship between Serum Anti Müllerian Hormone Level and Oocyte quality in In Vitro Fertilization Cycles
by: Fatemeh Keikha, et al.
Published: (2022)

Age effect on in vitro fertilization pregnancy mediated by anti-Mullerian hormone (AMH) and modified by follicle stimulating hormone (FSH)
by: Han-Chih Hsieh, et al.
Published: (2020)

Anti-Mullerian hormone levels decline under hormonal suppression: a prospective analysis in fertile women after delivery
by: Ortner Iris, et al.
Published: (2011)

Age and anti-Műllerian hormone: prediction of cumulative pregnancy outcome in in vitro fertilization with diminished ovarian reserve
by: Yu Deng, et al.
Published: (2021)

A review on the relationship between anti-mullerian hormone and fertility in treating young breast cancer patients
by: Yixuan Song, et al.
Published: (2021)

Efficacy of luteal estrogen administration and an early follicular Gonadotropin-releasing hormone antagonist priming protocol in poor responders undergoing fertilization
by: Hwajeong Lee, et al.
Published: (2018)

Fixed versus flexible gonadotropin releasing hormone antagonist protocol in women with polycystic ovary syndrome undergoing in vitro fertilization: An RCT
by: Hanieh Fatehi, et al.
Published: (2024)

AntiMüllerian Hormone Level in Laparoscopic Cystectomy
by: Edwin Budipramana, et al.
Published: (2016)

Interpretation and significance of the definition of anti-Mullerian hormone in the practice of juvenile gynaecologist
by: Zaira K. Kumykova, et al.
Published: (2021)

Anti-mullerian hormone levels before and after ovarian drilling in polycystic ovary syndrome: has this an effect on fertility?
by: Mojgan Javedani Masroor, et al.
Published: (2022)

The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor in myoma and adenomyosis
by: Shin Young Kim, et al.
Published: (2018)

Age-specific definition of low anti-Mullerian hormone and associated pregnancy outcome in women undergoing IVF treatment
by: Depeng Zhao, et al.
Published: (2021)

Anti-mullerian hormone cut-off values for predicting poor ovarian response to exogenous ovarian stimulation in in-vitro fertilization
by: Ruma Satwik, et al.
Published: (2012)

Predictive factors for pregnancy after intrauterine insemination: A prospective study of factors affecting outcome
by: Mohan S Kamath, et al.
Published: (2010)

Scheduling cycles with gonadotropin-releasing hormone antagonist protocol in in vitro fertilization: Is there a scope in batch in vitro fertilization?
by: Rohit Gutgutia, et al.
Published: (2014)

Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSI
by: Gültekin Adanaş Aydın, et al.
Published: (2015)

Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction
by: Y Himabindu, et al.
Published: (2013)

Blastocyst stage transfer vs cleavage stage embryo transfer
by: Ann M Mangalraj, et al.
Published: (2009)

Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study
by: Batool Hosein Rashidi, et al.
Published: (2019)

Establishment of a WHO Reference Reagent for anti-Mullerian hormone
by: Jackie Ferguson, et al.
Published: (2020)

Anti-mullerian hormon level and polycystic ovarian syndrome diagnosis
by: Shahrzad Zadehmodarres, et al.
Published: (2015)

A role of anti-Mullerian hormone in external genital endometriosis
by: A. S. Molotkov, et al.
Published: (2021)

Anti-Müllerian Hormone: A Personal View of the Empowering Analyte
by: Richard Fleming
Published: (2020)

About the Anti-Müllerian Hormone (AMH) Uses in the Clinical Practice
by: Gustavo Arantes Rosa Maciel, et al.
Published: (2018)

Anti-Mullerian Hormone Levels in Regularly Menstruating Nigerian Women
by: Olawale OO, et al.
Published: (2021)

Physiological role and diagnostic value of anti-Mullerian hormone in pediatrics
by: T.V. Sorokman, et al.
Published: (2022)

Cetrolix Protocol versus Conventional Clomiphene Citrate Protocol in Women with Unexplained Infertility Undergoing Intrauterine Insemination: A Randomised Prospective Study
by: Mostafa F, et al.
Published: (2016)

Symptomatic unilateral pleural effusion: A rare presentation of ovarian hyperstimulation syndrome
by: Korula George, et al.
Published: (2010)